Overview
HIV is a virus which attacks the immune system, and weakens
ability to fight infections and disease. Symptoms include fever, sore throat,
body rash, joint pain, muscle pain and swollen glands. The most common ways HIV
is spread are by having vaginal or anal intercourse without a condom with
someone who has HIV/AIDS, sharing needles or syringes with someone who has
HIV/AIDS, being deeply punctured with a needle or surgical instrument
contaminated with HIV and getting HIV-infected blood, semen, or vaginal secretions
into open wounds or sores.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Human
Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for
Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease),
complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type.
The Human Immunodeficiency Virus (HIV) Infections (AIDS)
(Infectious Disease) pipeline guide also reviews of key players involved in
therapeutic development for Human Immunodeficiency Virus (HIV) Infections
(AIDS) and features dormant and discontinued projects.
Human Immunodeficiency Virus (HIV) Infections (AIDS)
(Infectious Disease) pipeline guide helps in identifying and tracking emerging
players in the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555333-human-immunodeficiency-virus-hiv-infections-aids-pipeline-review-h1-2017
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Human Immunodeficiency Virus (HIV) Infections (AIDS)
(Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) therapeutics and enlists all their major and minor projects.
Table of Contents
Table of Contents 2
Introduction 9
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Overview 10
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Development 11
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Assessment 53
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Companies Involved in Therapeutics Development 71
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Drug Profiles 144
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Dormant Projects 829
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Discontinued Products 858
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Product Development Milestones 862
Appendix 875
Introduction 9
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Overview 10
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Development 11
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Assessment 53
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Companies Involved in Therapeutics Development 71
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Drug Profiles 144
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Dormant Projects 829
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Discontinued Products 858
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Product Development Milestones 862
Appendix 875
Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555333-human-immunodeficiency-virus-hiv-infections-aids-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
No comments:
Post a Comment